114 This may represent a pivotal shift, particularly for GLP-1RA, as it is based on metabolic improvement and has already been explored in some trials for exploratory research
A recent study shows people with obesity taking GLP-1 drugs are 20% less likely to suffer a cardiovascular event, and studies are under way for their use to treat the liver disease non-alcoholic steatohepatitis, as well as the neurodegenerative conditions Parkinsons and Alzheimers
While not as mainstream as injectables, they are growing in cultural presence as a "safer lane" for those seeking non-drug options
Taking your injection in the evening, ideally Sunday evening, means any initial digestive effects occur overnight and the following morning
When used under medical supervision, injectable GHK-Cu is well-tolerated with a strong safety profile
Insert the needle at a 45 to 90 degree angle (90 degrees for most people with adequate subcutaneous tissue, 45 degrees for leaner individuals)